These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2190427)

  • 21. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
    Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes toward methadone maintenance: implications for HIV prevention.
    Zule WA; Desmond DP
    J Psychoactive Drugs; 1998; 30(1):89-97. PubMed ID: 9565212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone in maintenance treatment of narcotic addicts; joint revision of conditions for use; interim maintenance treatment; human immunodeficiency virus disease counseling--FDA and SAMHSA. Final rule.
    Fed Regist; 1993 Jan; 58(3):495-9. PubMed ID: 10171334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary care of parenteral substance abusers.
    Williams A
    Nurse Pract; 1986 Jun; 11(6):17, 20, 25 passim. PubMed ID: 3459065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers.
    De Castro S; Sabaté E
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S464-7. PubMed ID: 14648465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inadequate treatment of opioid dependence due to society's attitudes and beliefs.
    Blansfield HN
    Conn Med; 1996 Jul; 60(7):423-8. PubMed ID: 8758660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of methadone maintenance.
    Barnett PG; Hui SS
    Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA; Resnick RB; Resnick E
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Hermann D; Klages E; Welzel H; Mann K; Croissant B
    Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Discussion on methadone programs in the Federal Republic of Germany].
    Schönhöfer PS; Hasse HE
    Dtsch Med Wochenschr; 1973 Oct; 98(43):2038-43. PubMed ID: 4200683
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quality of life for drug abusers accepting methadone maintenance treatment].
    Li XL; Tan HZ; Sun ZQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):601-5. PubMed ID: 18667773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants.
    Harper RG; Solish GI; Purow HM; Sang E; Panepinto WC
    Pediatrics; 1974 Sep; 54(3):300-5. PubMed ID: 4416175
    [No Abstract]   [Full Text] [Related]  

  • 38. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy in the context of narcotic addiction and methadone maintenance.
    Davis RC; Chappel JN
    Proc Natl Conf Methadone Treat; 1973; 2():1146-52. PubMed ID: 4808261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.